Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-02-23 @ 4:54 AM
Study NCT ID:
NCT02387957
Status:
TERMINATED
Last Update Posted:
2024-10-30
First Post:
2015-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Sponsor:
Organization: